Clinical Trial Update: A Study to Investigate Cabotegravir for Neonates Exposed to HIV-1 [Phase 1, Phase 2]

View source ↗

Summary

Early-phase clinical trial evaluating cabotegravir for preventing HIV infection in neonates exposed to HIV-1.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• HIV Infection

Drugs mentioned

• cabotegravir (cabotegravir)

Snippet

Sponsor: ViiV Healthcare | Conditions: HIV Infections | Phase 1, Phase 2 | Status: NOT_YET_RECRUITING